Position in MGNX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$96,852
+$93,864 QoQ
Shares Held
33,513
+1783.8% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,427,117,007 across 402 Biotechnology names. MGNX ranks #208 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in MGNX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $96,852 | 33,513 | Shares | Defined | 2026-05-11 | |
| 2025-09-30 | $2,988 | 1,779 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $42,579 | 35,190 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $58,237 | 45,857 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $162,983 | 50,149 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $150,164 | 45,643 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $104,698 | 24,635 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $4,490,718 | 305,076 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $447,050 | 46,471 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $10,181 | 2,185 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $109,716 | 20,508 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $13,945 | 1,945 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $16,458 | 2,453 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $13,462 | 3,891 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $18,590 | 6,302 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $317,917 | 36,086 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $2,323,237 | 144,750 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $2,955,094 | 141,122 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $5,118,951 | 190,579 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $4,432,595 | 139,171 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $364,182 | 15,931 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $233,057 | 9,252 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $863,816 | 30,939 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $225,827 | 38,802 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||